331 related articles for article (PubMed ID: 25814153)
1. Soluble VCAM-1 impairs human brain endothelial barrier integrity via integrin α-4-transduced outside-in signalling.
Haarmann A; Nowak E; Deiß A; van der Pol S; Monoranu CM; Kooij G; Müller N; van der Valk P; Stoll G; de Vries HE; Berberich-Siebelt F; Buttmann M
Acta Neuropathol; 2015 May; 129(5):639-52. PubMed ID: 25814153
[TBL] [Abstract][Full Text] [Related]
2. alpha4 Integrin/FN-CS1 mediated leukocyte adhesion to brain microvascular endothelial cells under flow conditions.
Man S; Tucky B; Bagheri N; Li X; Kochar R; Ransohoff RM
J Neuroimmunol; 2009 May; 210(1-2):92-9. PubMed ID: 19345424
[TBL] [Abstract][Full Text] [Related]
3. IFN-beta regulates CD73 and adenosine expression at the blood-brain barrier.
Niemelä J; Ifergan I; Yegutkin GG; Jalkanen S; Prat A; Airas L
Eur J Immunol; 2008 Oct; 38(10):2718-26. PubMed ID: 18825744
[TBL] [Abstract][Full Text] [Related]
4. Soluble serum VCAM-1, whole blood mRNA expression and treatment response in natalizumab-treated multiple sclerosis.
Petersen ER; Søndergaard HB; Oturai AB; Jensen P; Sorensen PS; Sellebjerg F; Börnsen L
Mult Scler Relat Disord; 2016 Nov; 10():66-72. PubMed ID: 27919501
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of TNF-alpha in soluble VCAM-1-induced angiogenesis through alpha 4 integrins.
Nakao S; Kuwano T; Ishibashi T; Kuwano M; Ono M
J Immunol; 2003 Jun; 170(11):5704-11. PubMed ID: 12759453
[TBL] [Abstract][Full Text] [Related]
6. Fingolimod prevents blood-brain barrier disruption induced by the sera from patients with multiple sclerosis.
Nishihara H; Shimizu F; Sano Y; Takeshita Y; Maeda T; Abe M; Koga M; Kanda T
PLoS One; 2015; 10(3):e0121488. PubMed ID: 25774903
[TBL] [Abstract][Full Text] [Related]
7. Natalizumab treatment reduces endothelial activity in MS patients.
Millonig A; Hegen H; Di Pauli F; Ehling R; Gneiss C; Hoelzl M; Künz B; Lutterotti A; Rudzki D; Berger T; Reindl M; Deisenhammer F
J Neuroimmunol; 2010 Oct; 227(1-2):190-4. PubMed ID: 20739072
[TBL] [Abstract][Full Text] [Related]
8. Effects of rIFN-beta-1b on serum circulating ICAM-1 in relapsing remitting multiple sclerosis and on the membrane-bound ICAM-1 expression on brain microvascular endothelial cells.
Trojano M; Defazio G; Avolio C; Paolicelli D; Giuliani F; Giorelli M; Livrea P
J Neurovirol; 2000 May; 6 Suppl 2():S47-51. PubMed ID: 10871785
[TBL] [Abstract][Full Text] [Related]
9. High levels of endothelial ICAM-1 prohibit natalizumab mediated abrogation of CD4
Soldati S; Bär A; Vladymyrov M; Glavin D; McGrath JL; Gosselet F; Nishihara H; Goelz S; Engelhardt B
J Neuroinflammation; 2023 May; 20(1):123. PubMed ID: 37221552
[TBL] [Abstract][Full Text] [Related]
10. Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis.
Ifergan I; Wosik K; Cayrol R; Kébir H; Auger C; Bernard M; Bouthillier A; Moumdjian R; Duquette P; Prat A
Ann Neurol; 2006 Jul; 60(1):45-55. PubMed ID: 16729291
[TBL] [Abstract][Full Text] [Related]
11. Reversibility of the effects of natalizumab on peripheral immune cell dynamics in MS patients.
Plavina T; Muralidharan KK; Kuesters G; Mikol D; Evans K; Subramanyam M; Nestorov I; Chen Y; Dong Q; Ho PR; Amarante D; Adams A; De Sèze J; Fox R; Gold R; Jeffery D; Kappos L; Montalban X; Weinstock-Guttman B; Hartung HP; Cree BAC
Neurology; 2017 Oct; 89(15):1584-1593. PubMed ID: 28916537
[TBL] [Abstract][Full Text] [Related]
12. Gene expression analysis of the microvascular compartment in multiple sclerosis using laser microdissected blood vessels.
Cunnea P; McMahon J; O'Connell E; Mashayekhi K; Fitzgerald U; McQuaid S
Acta Neuropathol; 2010 May; 119(5):601-15. PubMed ID: 19967542
[TBL] [Abstract][Full Text] [Related]
13. Interferon-beta-1a induces increases in vascular cell adhesion molecule: implications for its mode of action in multiple sclerosis.
Graber J; Zhan M; Ford D; Kursch F; Francis G; Bever C; Panitch H; Calabresi PA; Dhib-Jalbut S
J Neuroimmunol; 2005 Apr; 161(1-2):169-76. PubMed ID: 15748956
[TBL] [Abstract][Full Text] [Related]
14. Fingolimod (FTY720-P) Does Not Stabilize the Blood-Brain Barrier under Inflammatory Conditions in an in Vitro Model.
Schuhmann MK; Bittner S; Meuth SG; Kleinschnitz C; Fluri F
Int J Mol Sci; 2015 Dec; 16(12):29454-66. PubMed ID: 26690412
[TBL] [Abstract][Full Text] [Related]
15. CC chemokines and transmigration of eosinophils in the presence of vascular cell adhesion molecule 1.
Yamamoto H; Nagata M; Sakamoto Y
Ann Allergy Asthma Immunol; 2005 Feb; 94(2):292-300. PubMed ID: 15765748
[TBL] [Abstract][Full Text] [Related]
16. IL-1β promotes transendothelial migration of PBMCs by upregulation of the FN/α
Labus J; Wöltje K; Stolte KN; Häckel S; Kim KS; Hildmann A; Danker K
Exp Cell Res; 2018 Dec; 373(1-2):99-111. PubMed ID: 30342992
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin preserved blood brain barrier against cytokine induced alterations: possible role in multiple sclerosis.
Basivireddy J; Somvanshi RK; Romero IA; Weksler BB; Couraud PO; Oger J; Kumar U
Biochem Pharmacol; 2013 Aug; 86(4):497-507. PubMed ID: 23770458
[TBL] [Abstract][Full Text] [Related]
18. Astrocyte-derived retinoic acid: a novel regulator of blood-brain barrier function in multiple sclerosis.
Mizee MR; Nijland PG; van der Pol SM; Drexhage JA; van Het Hof B; Mebius R; van der Valk P; van Horssen J; Reijerkerk A; de Vries HE
Acta Neuropathol; 2014 Nov; 128(5):691-703. PubMed ID: 25149081
[TBL] [Abstract][Full Text] [Related]
19. Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflammatory stimuli.
Silwedel C; Förster C
J Neuroimmunol; 2006 Oct; 179(1-2):37-45. PubMed ID: 16884785
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of monomethyl fumarate at the inflamed blood-brain barrier.
Lim JL; van der Pol SM; Di Dio F; van Het Hof B; Kooij G; de Vries HE; van Horssen J
Microvasc Res; 2016 May; 105():61-9. PubMed ID: 26679389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
